The PINK1 gene helps cells check the health of mitochondria, the parts that make energy. This gene helps your body tag worn out mitochondria so cells can clear them away and keep nerve cells working well. If the gene does not work properly, damaged mitochondria can build up and stress brain cells that control movement. Certain inherited variants in the PINK1 gene can cause a form of Parkinson disease that often starts at a younger age.
What is a gene?
Genes are stretches of DNA that carry instructions your cells use to make molecules or regulate activities in the body. Some genes provide the directions for producing proteins, the parts of cells that do much of the work. Other genes mainly guide when certain processes happen, where they happen, and how active they are. Together, genes affect how the body develops and works, and they can shape how you respond to food, stress, or medications. For a deeper look at this topic, you can learn more in the LearnHub.
Overview
PINK1Gene function
What if the gene works
The PINK1 gene helps cells monitor and clear damaged mitochondria, the parts that make energy. This supports steady energy production and is especially important for brain cells that need a reliable energy supply.
Risk
What if the gene does not work
Loss of both working copies of the PINK1 gene can cause early-onset Parkinson disease, often with slowness, stiffness, tremor, and balance problems. Milder and more severe variants may influence when symptoms begin and how strongly they affect daily life.
Treatment
What does that mean for your treatment
No treatment specific to pathogenic variants in the PINK1 gene is currently established in clinical guidelines. Research is exploring drugs that boost the PINK1 pathway and help cells clear damaged mitochondria (their energy making parts), but these approaches remain investigational.
Conditions associated with PINK1
Gene function
What if the gene works
Your cells depend on the PINK1 gene to keep their energy making parts working well. It is especially active in protecting mitochondria, the small structures that supply power for daily cell tasks. This helps explain the PINK1 gene’s role in mitochondrial quality control, the routine process cells use to check, label, and clear worn out mitochondria.
The PINK1 gene helps cells monitor the condition of mitochondria. When a mitochondrion is not working at its best, PINK1 gathers on its surface and acts like an early warning signal.
One of its main roles is to help your cells mark worn out mitochondria for cleanup. PINK1 passes signals to other proteins, including the PRKN gene protein, so the cell can remove parts that are no longer working well.
By guiding this quality check, the PINK1 gene helps cells keep a healthier pool of mitochondria. This supports steadier energy production for tissues that need a lot of power, such as the brain and muscles.
What is a variant?
A genetic variant is a small alteration in the DNA sequence within a gene. These changes are common and form part of normal human diversity, including differences in appearance, metabolism, and how the body responds to environmental influences. Many variants do not cause any noticeable effect and simply represent natural genetic variation. In some situations, though, a variant can change how a gene functions more substantially and may contribute to or cause a genetic condition.
Genetic variants
What if the gene does not work
Variants in the PINK1 gene linked to early onset Parkinson disease can shorten the protein, make it unstable, or reduce its kinase activity, so damaged mitochondria are not marked properly for removal. Some are milder missense variants that leave partial function, while stop, frameshift, or deletion variants often cause a larger loss of function. When both copies of the PINK1 gene are affected, greater functional loss can be associated with earlier symptom onset or more marked features, although this varies from person to person.
How variants are linked to conditions
Pathogenic variants in the PINK1 gene can cause an inherited form of Parkinson disease that often begins before age 50, and sometimes much earlier. This well-established PINK1 gene link to early-onset Parkinson disease is usually seen when a person inherits a pathogenic variant from both parents. People with PINK1-related Parkinson disease may notice tremor, stiffness, slower movement, or changes in walking and balance.
A variant is not necessarily a diagnosis
Genetic variants are a usual part of human biology and are common across the general population. Most do not have a direct effect on health and simply contribute to natural human diversity. For many genes, having a variant associated with a condition suggests a possible link rather than a definite diagnosis, especially when several genes and environmental influences are involved. In some situations, though, a single well-characterized variant in a specific gene is enough to confirm a diagnosis.
Are there things that can increase or change my risk?
For PINK1, risk is mainly shaped by the specific gene change and whether one or both copies of the gene are affected. People with changes in both copies have a much higher chance of developing young-onset Parkinson disease, but the age symptoms begin and severity can still vary. Specific lifestyle or environmental factors that clearly change this risk have not been firmly confirmed.
Inheritance of PINK1 variants
PINK1-related Parkinson disease is inherited in an autosomal recessive pattern. In practical terms, this means a person usually develops the condition only if they inherit two disease-causing variants in the PINK1 gene, one from each parent. Parents who each carry one variant are typically unaffected carriers. When both parents are carriers, each child has a 25% chance of inheriting both variants, a 50% chance of being a carrier, and a 25% chance of inheriting neither variant.
What does my PINK1 result mean for my family?
For families with a disease-causing PINK1 result linked to early-onset Parkinson disease, this usually follows a recessive pattern, so brothers and sisters may also have the condition or be carriers even if they feel well. Parents are often healthy carriers. Children of someone with two changed PINK1 copies usually inherit one changed copy and are carriers, unless the other parent also carries a PINK1 change.
Genetic information
Genetic testing
How you find out about variants
Genetic testing for PINK1 variants uses a blood, saliva, or cheek swab sample to read the PINK1 gene and look for changes in its DNA code. Results may show a known pathogenic variant, no relevant variant, or a variant of uncertain significance that needs careful interpretation.
When should I consider getting a genetic test?
Genetic testing for the PINK1 gene may be worth considering if Parkinson’s symptoms begin at a young age, especially before age 50, or if several family members have Parkinson’s disease. It can also help clarify risk for close relatives when a PINK1 gene change is already known in the family.
A genetic result is only one part of your health story
A genetic result can provide useful insight, but how much it explains varies by the condition and the kind of variant involved. Over time, many factors, including lifestyle, environment, age, and medical history, also influence how the body functions. For some conditions, particularly those shaped by many genes, genetic information offers context rather than certainty and is best considered together with other parts of care. In other situations, a genetic result may give a clear answer. In areas such as medication response, genetic results can also help put individual experiences into context.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how people respond to medicines. This helps explain why the same treatment works well for one person but less well for another, or why some people are more likely to notice side effects. Small differences in genes can change how the body breaks down, moves, or responds to a drug. These differences are common and can influence how effective a medicine feels and how sensitive someone may be to it.
What is Pharmacogenetics?
Pharmacogenetics examines how genetic differences shape the way people respond to medications. It studies the relationship between genes and drugs to better explain why the same treatment can affect one person differently than another. For many medicines, genes influence either how strongly a drug works or how the body handles it. This understanding can support treatment decisions that are both more informed and more individualized. More detailed information on this topic is available in the LearnHub.
Drugs influenced by the PINK1 gene
When should I seek medical advice?
There is not yet a broadly confirmed role for this gene in guiding medication choices. Questions about medicines, side effects, or changes in your health are best discussed with your doctor.
History
Researchers identified the PINK1 gene in 2004 while studying families with inherited early onset Parkinson disease. This discovery helped explain why some people develop Parkinson symptoms at a younger age, sometimes in early adult life. From these first observations, research expanded steadily. Soon after, scientists recognized PINK1 as one of the key genes linked to recessive forms of Parkinson disease, where a person inherits a variant from each parent. Work on the PINK1 gene also shaped broader Parkinson research by drawing attention to the role of cell energy systems, especially mitochondria. Today, its history remains closely tied to major advances in understanding the genetic forms of Parkinson disease.